2 exciting small cap ASX shares named as buys

Check out these small cap shares…

| More on:
A young man working from home sits at his home office desk holding a cup of tea and looking out the window

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're wanting to invest in the small side of the Australian share market, then the small caps listed below could be worth a closer look.

Both of these shares have been named as buys and tipped for big things in the future. Here's why these small cap ASX shares could be worth adding to your watchlist:

Catapult Group International Ltd (ASX: CAT)

The first small cap to look at is Catapult. It is a global sports analytics company that provides elite sporting organisations and athletes with real time data and analytics to monitor and measure athletes.

The company's technology is used by many of the biggest and most successful sports teams and organisations across the world. And while demand softened at the height of the pandemic, it has rebounded strongly since then.

For example, Catapult reported a 13% increase in revenue to $37.5 million during the first half of FY 2022. This was driven by 29% growth in subscription revenue, which management notes reflects Catapult's strategic shift to a focus on high quality recurring revenue SaaS deals.

Jefferies is a fan. It currently has a buy rating and $3.00 price target on the company's shares.

Volpara Health Technologies Ltd (ASX: VHT)

Another small cap to look at is Volpara. It is a growing MedTech software as a service company and the provider of breast imaging analytics and analysis products.

Its products improve clinical decision-making and support the early detection of breast cancer. Demand has been growing strongly in recent years and has continued in FY 2022. During the second quarter, the company reported a 63% increase in subscription based revenue. This took its annualised recurring revenue to US$20.4 million at the end of the period.

The good news for investors is that this is still only a fraction of its US$750 million addressable market in just breast cancer screening. It also has its eyes on other markets such as lung cancer screening.

Morgans currently has an add rating and $1.87 price target on the company's shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Catapult Group International Ltd and VOLPARA FPO NZ. The Motley Fool Australia owns and has recommended Catapult Group International Ltd and VOLPARA FPO NZ. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Small Cap Shares

Two brokers analysing stocks.
Small Cap Shares

Broker tips these 3 ASX small-cap healthcare stocks to rise 56%, 79% and 130%

These 3 ASX small-cap stocks could deliver substantial returns.

Read more »

growth charts with small cap written on a sticky note
Small Cap Shares

Expert names 3 ASX small-cap stocks to buy in July

ASX small-cap stocks have greater ability to generate outsized returns, but can be difficult to discover.

Read more »

Two funeral workers with a laptop surrounded by cofins.
Small Cap Shares

Why I think this ASX small-cap stock is a bargain at $4.74

This business has excellent long-term growth potential.

Read more »

A man in trendy clothing sits on a bench in a shopping mall looking at his phone with interest and a surprised look on his face.
Small Cap Shares

Why I think this ASX small-cap stock is a bargain at $3.36

This business could continue revving higher…

Read more »

A young boy wearing a hat, sunnies and striped singlet looks fierce and flexes his arm in victory.
Small Cap Shares

Why this ASX small-cap stock has significant potential

This business is delivering significant growth.

Read more »

Five young boys wearing small caps sit on a bench together watching a baseball game.
Small Cap Shares

5 ASX small-cap shares that screamed 114% to 362% higher in FY25

Here are some examples of ASX small-cap shares that experienced outstanding price growth in FY25.

Read more »

Three young people in business attire sit around a desk and discuss.
Small Cap Shares

Tiny tech: 3 ASX small-cap shares with new ratings

Toby Grimm of Baker Young and Peter Day of Sequoia Wealth Management share their new ratings.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Small Cap Shares

Hidden gems: Experts name 3 ASX small-cap shares to buy now

One of these ASX small-cap shares has risen by a staggering 1,687% over the past 12 months.

Read more »